The most consequential number in this article is old, unglamorous, and almost never quoted to patients. Roughly 12% of the overall prevalence of symptomatic osteoarthritis of the hip, knee and ankle in the United States is post-traumatic in origin. In the population estimate that produced it, that corresponds to about 5.6 million people, and about $3.06 billion a year in direct cost.
One in eight symptomatic arthritic joints did not wear out. It was injured, and then the years did the rest.
What happens on day one that a radiograph will show in year fifteen
The impact is not only mechanical. Three processes start at the moment of injury and none of them is visible on the imaging ordered that week.
- Chondrocyte death. The load transient itself kills cells in the cartilage matrix. Those cells maintained the matrix. Fewer of them means slower turnover in a tissue that was already turning over slowly.
- A catabolic shift in the joint fluid. The synovium reacts to blood and debris, and the fluid the cartilage lives in changes character: the enzymes that break matrix down gain ground on the machinery that builds it. This is a chemical state, and it outlasts visible swelling by a long way.
- Altered kinematics. A ligament that healed long, a meniscus that no longer distributes load, or a limb that is being guarded, all change where load lands. Cartilage tolerates enormous load distributed correctly and very little load concentrated wrongly.
Reviews of osteoarthritis after anterior cruciate ligament injury reach an uncomfortable conclusion that is worth stating plainly: reconstructing the ligament restores stability and does not reliably prevent the arthritis. A graft answers the mechanical half of a two-part problem. The chemical half is left exactly where it was, and it does not resolve itself out of gratitude.
The ankle is the cleanest illustration
Knees and hips wear out for many reasons, so post-traumatic cases hide in the crowd. The tibiotalar joint rarely wears out on its own; when an ankle is arthritic there is usually an event in the history. It is also the joint most likely to have been dismissed at the time.
A systematic review and meta-analysis of first-time lateral ankle sprains put residual pain at 48.6% at three months, 21.5% at six months and 6.7% at twelve, with a recurrent sprain in 15.8% within the year. Most settle. The ones that do not are the ones with a joint that has been loading abnormally for a decade before anybody looks at it again.
What is still modifiable, and for how long
This is where the pessimistic reading of the data goes wrong. The trajectory is not fixed on day one; what is fixed on day one is the starting position. Three things stay modifiable for years.
The chemical environment
A joint carrying a low-grade inflammatory state degrades faster than the same joint in a quiet one, and systemic inflammatory load is a contributor to the local state rather than a separate topic. That is a measurable, treatable variable, and it is the reason the metabolic audit is run before anything else here.
The loading pattern
Muscle that controls where load lands is the joint's only real protection, and it is lost quickly after an injury and regained slowly. This is not a fitness recommendation. It is a mechanical intervention on the variable that decides cartilage stress, and it is argued in full in why load is the treatment.
What is done next, and what is not done
A ten-year randomized follow-up is instructive here, with the caveat that it studied degenerative rather than traumatic tears: 140 people with a degenerative meniscal tear and minimal radiographic change were randomized to arthroscopic partial meniscectomy or twelve weeks of exercise therapy. At ten years, radiographic osteoarthritis had developed in 23% of the surgery group and 20% of the exercise group, with no clinically relevant difference in patient-reported outcomes or muscle strength.
Twelve weeks of structured exercise matched an operation over a decade. That is not an argument against surgery when surgery is indicated. It is an argument that the intervention with the best ten-year record in that population was the one that changed how the joint was loaded.
What an injection can and cannot claim here
Nothing has been shown to prevent post-traumatic osteoarthritis, and a practice that tells you otherwise is selling. What the graded evidence supports is symptom and function benefit in established osteoarthritis: the ESSKA-ORBIT consensus places its grade A statement on clinical effectiveness at Kellgren-Lawrence grade 3 or below, and a network meta-analysis found platelet-rich plasma, bone marrow concentrate and hyaluronic acid all outperforming corticosteroid on pain and function at six months or beyond.
So the honest framing for a post-traumatic joint is a long one. Manage the environment. Manage the load. Use a catalyst where a target and a window justify it. Reassess on a schedule rather than when it gets bad enough to prompt a call.
Frequently Asked Questions
Is post-traumatic arthritis inevitable after a ligament injury?
It is not inevitable and it is common enough that it should be planned for rather than hoped against, because the reviews are consistent that reconstructing a ligament restores stability without reliably preventing the arthritis. What the radiographic grade does and does not tell you along the way is covered in Kellgren-Lawrence knee osteoarthritis grading.
How long does it take for a post-traumatic joint to become symptomatic?
Years, usually, which is exactly what makes it easy to ignore while it is still modifiable. The interval between the event and the first bad radiograph is the interval in which terrain and loading are still deciding the outcome, and it is the period described in Metabolic terrain: why joint degeneration is not only mechanical.
I am in my thirties and I injured my knee. Is that better or worse than doing it at sixty?
Biologically better and strategically worse, because a younger joint repairs more readily and also has forty more years to spend under whatever conditions you set now. That is the argument against deferring the question, and it is why the window before a joint replacement becomes the conversation matters more at that age, not less.
Does an early MRI finding of a bone bruise mean anything?
It can, because subchondral marrow signal after an impact reflects the bone taking load the cartilage no longer distributes evenly, and it is a marker worth following rather than a curiosity. What those lesions mean over time is set out in Subchondral bone marrow lesions on knee MRI.
Can an injection stop this trajectory?
Nothing has been shown to prevent post-traumatic osteoarthritis, and we will not claim it. What can be treated is the inflammatory environment and the loading pattern the joint lives in, which is a symptom and function argument rather than a structural one — a distinction made carefully in Advanced knee osteoarthritis: when PRP is a bridge, not a substitute.
Find out what your recovery is actually limited by
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, your imaging and your metabolic data, and a written terrain roadmap before any procedure is discussed. Evaluation is contingent upon review of your data.
Questions? Call (314) 295-3000 or text (314) 886-5902.
Sources
- Brown TD, Johnston RC, Saltzman CL, et al. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma, 2006. PubMed 17106388 doi:10.1097/01.bot.0000246468.80635.ef
- Racine J, Aaron RK. Post-traumatic osteoarthritis after ACL injury. R I Med J, 2014. PubMed 25365816
- Wang LJ, Zeng N, Yan ZP, et al. Post-traumatic osteoarthritis following ACL injury. Arthritis Res Ther, 2020. PubMed 32209130 doi:10.1186/s13075-020-02156-5
- Kon E, Di Matteo B, Delgado D, et al. Platelet-rich plasma injections for the management of knee osteoarthritis: the ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surg Sports Traumatol Arthrosc, 2024. PubMed 38961773 doi:10.1002/ksa.12320
- Laver L, Filardo G, Sanchez M, et al. The use of injectable orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus. Part 1 — blood-derived products (platelet-rich plasma). Knee Surg Sports Traumatol Arthrosc, 2024. PubMed 38436492 doi:10.1002/ksa.12077
- Jawanda H, Khan ZA, Warrier AA, et al. Platelet-rich plasma, bone marrow aspirate concentrate, and hyaluronic acid injections outperform corticosteroids in pain and function scores at a minimum of 6 months as intra-articular injections for knee osteoarthritis: a systematic review and network meta-analysis. Arthroscopy, 2024. PubMed 38331363 doi:10.1016/j.arthro.2024.01.037
- Michels F, Wastyn H, Pottel H, Stockmans F. The presence of persistent symptoms 12 months following a first lateral ankle sprain: a systematic review and meta-analysis. Foot Ankle Surg, 2022. PubMed 34961654 doi:10.1016/j.fas.2021.12.002
- Berg B, Roos EM, Englund M, et al. Arthroscopic partial meniscectomy versus exercise therapy for degenerative meniscal tears: 10-year follow-up of the OMEX randomised controlled trial. Br J Sports Med, 2025. PubMed 39326908 doi:10.1136/bjsports-2024-108644